{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=meropenem&page=2", "query": { "intervention": "meropenem", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=meropenem&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-15T01:51:47.042Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02168946", "title": "Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infection Complicated", "Acute Pyelonephritis", "Hospital Acquired Bacterial Pneumonia", "Ventilator-associated Bacterial Pneumonia", "Bacteremia", "Abdominal Infection" ], "interventions": [ { "name": "Vabomere", "type": "DRUG" }, { "name": "Best Available Therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2014-07", "completion_date": "2017-07-21", "has_results": true, "last_update_posted_date": "2019-03-04", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 20, "location_summary": "Hartford, Connecticut • Tampa, Florida • Augusta, Georgia + 16 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02168946" }, { "nct_id": "NCT02166476", "title": "Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Tract Infection Complicated", "Acute Pyelonephritis" ], "interventions": [ { "name": "Meropenem-Vaborbactam", "type": "DRUG" }, { "name": "Piperacillin-Tazobactam", "type": "DRUG" }, { "name": "Levofloxacin", "type": "DRUG" }, { "name": "Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 550, "start_date": "2014-11-20", "completion_date": "2016-04-28", "has_results": true, "last_update_posted_date": "2018-06-11", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 8, "location_summary": "Mobile, Alabama • San Diego, California • Denver, Colorado + 5 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Tampa", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02166476" }, { "nct_id": "NCT01499290", "title": "Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-Abdominal Infection" ], "interventions": [ { "name": "CAZ-AVI", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 493, "start_date": "2012-03", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2017-09-06", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 4, "location_summary": "Chula Vista, California • San Diego, California • St Louis, Missouri + 1 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Somers Point", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01499290" }, { "nct_id": "NCT02732327", "title": "Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neoplasms", "Febrile Neutropenia" ], "interventions": [ { "name": "CAZ-AVI", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" }, { "name": "Cefepime", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Piperacillin/tazobactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2016-05-17", "completion_date": "2016-06-27", "has_results": true, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02732327" }, { "nct_id": "NCT01445678", "title": "Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-abdominal Infection" ], "interventions": [ { "name": "CXA-201 and metronidazole", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 494, "start_date": "2011-12-23", "completion_date": "2013-10-15", "has_results": true, "last_update_posted_date": "2018-11-16", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 4, "location_summary": "Springfield, Illinois • Boston, Massachusetts • Robbinsdale, Minnesota + 1 more", "locations": [ { "city": "Springfield", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Robbinsdale", "state": "Minnesota" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01445678" }, { "nct_id": "NCT02784704", "title": "Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Intra-abdominal Infections", "Complicated Appendicitis" ], "interventions": [ { "name": "Eravacycline", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tetraphase Pharmaceuticals, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2016-10-13", "completion_date": "2017-05-19", "has_results": true, "last_update_posted_date": "2022-01-06", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 6, "location_summary": "Los Angeles, California • Indianapolis, Indiana • Las Vegas, Nevada + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Las Vegas", "state": "Nevada" }, { "city": "Somers Point", "state": "New Jersey" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02784704" }, { "nct_id": "NCT03582007", "title": "Pivotal Study in Nosocomial Pneumonia Suspected or Confirmed to be Due to Pseudomonas", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumonia" ], "interventions": [ { "name": "Murepavadin", "type": "DRUG" }, { "name": "One anti-pseudomonal antibiotic", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Polyphor Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2018-10-22", "completion_date": "2019-07-17", "has_results": false, "last_update_posted_date": "2019-08-28", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 2, "location_summary": "Iowa City, Iowa • Pittsburgh, Pennsylvania", "locations": [ { "city": "Iowa City", "state": "Iowa" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03582007" }, { "nct_id": "NCT02475733", "title": "Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Complicated Intra-abdominal Infections" ], "interventions": [ { "name": "Ceftazidime -avibactam", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" }, { "name": "Metronidazole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "3 Months to 17 Years" }, "enrollment_count": 83, "start_date": "2015-08-01", "completion_date": "2017-06-01", "has_results": true, "last_update_posted_date": "2018-08-09", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 4, "location_summary": "Orange, California • San Diego, California • Toledo, Ohio + 1 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Toledo", "state": "Ohio" }, { "city": "Tulsa", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT02475733" }, { "nct_id": "NCT05204368", "title": "Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Complicated Urinary Tract Infection Including Acute Pyelonephritis" ], "interventions": [ { "name": "Combination of Imipenem/Cilastatin and XNW4107", "type": "DRUG" }, { "name": "Meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Evopoint Biosciences Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 780, "start_date": "2023-03-30", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2023-02-16", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05204368" }, { "nct_id": "NCT01429259", "title": "Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis", "Pneumonia", "Pseudomonas Aeruginosa Infection" ], "interventions": [ { "name": "meropenem", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Joseph Kuti", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2012-02", "completion_date": "2014-01", "has_results": true, "last_update_posted_date": "2018-03-20", "last_synced_at": "2026-09-15T01:51:47.042Z", "location_count": 7, "location_summary": "Hartford, Connecticut • Indianapolis, Indiana • New York, New York + 4 more", "locations": [ { "city": "Hartford", "state": "Connecticut" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "New York", "state": "New York" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01429259" } ] }